MassDevice

Boston Scientific reports positive findings for Ekos endovascular system in pulmonary embolism

Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS endovascular system.
MassDevice

The biggest cardiology tech stories out of ACC 2026

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...
Endovascular Today

HI-PEITHO: Boston Scientific’s Ekos System Superior to Anticoagulation Alone in Acute Intermediate-Risk PE

Boston Scientific Corporation announced that the HI-PEITHO global randomized clinical trial evaluating the use of the Ekos endova ...
KTBS 3

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. antico ...

Are Boston Scientific’s (BSX) New Trial Wins Quietly Redefining Its Minimally Invasive Care Advantage?

In late March 2026, Boston Scientific reported three advances: positive CHAMPION-AF and HI-PEITHO trial results for its ...